LEP and metabolic dysfunction-associated steatotic liver disease: Nonetheless, the finding of leptin analogs that preserve the anti-steatotic profile and lack the potential inflammatory and fibrogenic actions would be of paramount importance [12] in the search for NAFLD treatments.